These results provide a molecular explanation for the decreased CD8 count and loss of CTL-mediated killing giving rise to increased susceptibility to acute as well as the more chronic viral infections, as observed in ARPC1B-deficient patients. The gene discussed is ARPC1B; the disease is viral infectious disease.